REDHILL BIOPHARMA LTD. (RDHL) Free cash flow 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.4MFY2024 · since FY2015: -$17.8M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$9.4M | +73.8% |
| FY2023 | -$35.8M | -21.9% |
| FY2022 | -$29.4M | +54.9% |
| FY2021 | -$65.2M | -33.0% |
| FY2020 | -$49.0M | -19.7% |
| FY2019 | -$40.9M | -18.7% |
| FY2018 | -$34.5M | +23.2% |
| FY2017 | -$44.9M | -58.5% |
| FY2016 | -$28.3M | -58.9% |
| FY2015 | -$17.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice